AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive: Since PTEN is a major regulating pathway of PI3K/Akt/mTOR signaling, loss of PTEN contributes to the upregulation of this signaling cascade, eventually resulting in enhanced cell proliferation and chemoresistance in AML, CML, and ALL.